Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads In Diabetes
Diabetes for January/February 2015
FDA Approves Dual Type 2 Diabetes Pill, First SGLT2 and DPP-4 inhibitors combination
Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
FDA Approves Dual Type 2 Diabetes Pill, First SGLT2 and DPP-4 inhibitors combination